Insights

Strategic partnerships Target established cardiovascular device players and contract manufacturers for potential licensing, co-development, or distribution deals to accelerate manufacturing scale and regulatory pathways for MCC3000 technology.

Clinical advocacy Highlight opportunities to collaborate with renowned clinicians and advisory boards to validate efficacy, publish outcomes, and build peer-driven demand with hospitals and trauma centers.

Funding & grants Explore government and private grant programs, angel investors, and strategic industry investment to increase funding for early-stage clinical trials and pilot deployments in hospital settings.

Target market entry Position MCC3000 as a bridge-to-surgery or transplant support device to hospitals and cardiac centers with high ARDS and cardiac arrest volumes, emphasizing time-to-treatment advantages.

Operational readiness Leverage low company size to offer flexible procurement, rapid pilots, and personalized service agreements, while showcasing scalable manufacturing and regulatory milestones to potential buyers.

MyoCardioCare, Inc. Tech Stack

MyoCardioCare, Inc. uses 8 technology products and services including Google Cloud CDN, Open Graph, Google Cloud, and more. Explore MyoCardioCare, Inc.'s tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • MooTools
    Javascript Frameworks
  • Zepto
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • PHP
    Programming Languages
  • Bootstrap
    UI Frameworks

MyoCardioCare, Inc.'s Email Address Formats

MyoCardioCare, Inc. uses at least 1 format(s):
MyoCardioCare, Inc. Email FormatsExamplePercentage
First@myocardiocare.comJohn@myocardiocare.com
100%

Frequently Asked Questions

Where is MyoCardioCare, Inc.'s headquarters located?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s main headquarters is located at United States. The company has employees across 1 continents, including North America.

What is MyoCardioCare, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s official website is myocardiocare.com and has social profiles on LinkedIn.

What is MyoCardioCare, Inc.'s NAICS code?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does MyoCardioCare, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, MyoCardioCare, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Co-Founder: S. S.. Explore MyoCardioCare, Inc.'s employee directory with LeadIQ.

What industry does MyoCardioCare, Inc. belong to?

Minus sign iconPlus sign icon
MyoCardioCare, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does MyoCardioCare, Inc. use?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s tech stack includes Google Cloud CDNOpen GraphGoogle CloudMooToolsZeptoMicrosoft WordPHPBootstrap.

What is MyoCardioCare, Inc.'s email format?

Minus sign iconPlus sign icon
MyoCardioCare, Inc.'s email format typically follows the pattern of First@myocardiocare.com. Find more MyoCardioCare, Inc. email formats with LeadIQ.

How much funding has MyoCardioCare, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, MyoCardioCare, Inc. has raised $25K in funding. The last funding round occurred on Jan 02, 2018 for $25K.
MyoCardioCare, Inc. logo

MyoCardioCare, Inc.

Medical Equipment ManufacturingUnited States2-10 Employees

MyoCardioCare, Inc. is a privately held medical device company based in the United States that was founded in 2009 to advance a novel heart-support technology. The firm is developing a single-use, pneumatically powered device designed to rhythmically compress and expand the heart in order to restore and maintain circulation during cardiac arrest, with the goal of providing a bridge to more definitive therapies such as surgery or transplant. Target customers are healthcare providers treating patients experiencing acute circulatory failure, where existing interventions may be ineffective or slow, and the device aims to improve outcomes by offering timely circulatory support. The company operates within the medical equipment manufacturing industry and is positioned as a developer of life-saving acute circulatory support systems, leveraging early prototypes and research from academic settings to inform its approach. A recent development noted is the appointment of Dr. Brian Gibler to its Scientific Advisory Board in May 2018, reflecting ongoing scientific collaboration as it advances toward commercialization.

Section iconCompany Overview

Headquarters
United States
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $25K

    MyoCardioCare, Inc. has raised a total of $25K of funding over 1 rounds. Their latest funding round was raised on Jan 02, 2018 in the amount of $25K.

  • $1M

    MyoCardioCare, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $25K

    MyoCardioCare, Inc. has raised a total of $25K of funding over 1 rounds. Their latest funding round was raised on Jan 02, 2018 in the amount of $25K.

  • $1M

    MyoCardioCare, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.